WallStreetZenWallStreetZen

NYSE: HRT
Hireright Holdings Corp Stock Forecast, Predictions & Price Target

Analyst price target for HRT

Based on 2 analysts offering 12 month price targets for Hireright Holdings Corp.
Min Forecast
$11.00-22.92%
Avg Forecast
$13.00-8.9%
Max Forecast
$15.00+5.12%

Should I buy or sell HRT stock?

Based on 2 analysts offering ratings for Hireright Holdings Corp.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HRT stock forecasts and price targets.

HRT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-11
lockedlocked$00.00+00.00%2023-11-08

1 of 1

Forecast return on equity

Is HRT forecast to generate an efficient return?
Company
N/A
Industry
66.58%
Market
29.75%

Forecast return on assets

Is HRT forecast to generate an efficient return on assets?
Company
N/A
Industry
9.23%

HRT revenue forecast

What is HRT's revenue in the next 2 years based on estimates from 4 analysts?
Avg 1 year Forecast
$755.6M+4.67%
Avg 2 year Forecast
$861.0M+19.27%
HRT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HRT revenue growth forecast

How is HRT forecast to perform vs Staffing & Employment Services companies and vs the US market?
Company
4.67%
Industry
3.36%
Market
13.23%
HRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HRT vs Staffing & Employment Service Stocks

TickerPricePrice TargetUp/downsideConsensus
HRT$14.27$13.00-8.90%Buy
ZIP$10.62$13.67+28.69%Hold
KELYA$24.23$26.00+7.30%Buy
BBSI$123.80$141.00+13.89%Buy
KFRC$64.08$68.33+6.64%Hold

Hireright Holdings Stock Forecast FAQ

Is Hireright Holdings Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: HRT) stock is to Buy HRT stock.

Out of 2 analysts, 0 (0%) are recommending HRT as a Strong Buy, 1 (50%) are recommending HRT as a Buy, 1 (50%) are recommending HRT as a Hold, 0 (0%) are recommending HRT as a Sell, and 0 (0%) are recommending HRT as a Strong Sell.

If you're new to stock investing, here's how to buy Hireright Holdings stock.

What is HRT's revenue growth forecast for 2024-2025?

(NYSE: HRT) Hireright Holdings's forecast annual revenue growth rate of 4.67% is forecast to beat the US Staffing & Employment Services industry's average forecast revenue growth rate of 3.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.23%.

Hireright Holdings's revenue in 2024 is $721,877,000.On average, 4 Wall Street analysts forecast HRT's revenue for 2024 to be $50,890,213,508, with the lowest HRT revenue forecast at $48,878,043,798, and the highest HRT revenue forecast at $52,097,515,334.

In 2025, HRT is forecast to generate $57,990,899,421 in revenue, with the lowest revenue forecast at $57,990,899,421 and the highest revenue forecast at $57,990,899,421.

What is HRT's forecast return on assets (ROA) for 2024-2025?

(NYSE: HRT) forecast ROA is N/A, which is lower than the forecast US Staffing & Employment Services industry average of 9.23%.

What is HRT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year HRT price target, the average HRT price target is $13.00, with the highest HRT stock price forecast at $15.00 and the lowest HRT stock price forecast at $11.00.

On average, Wall Street analysts predict that Hireright Holdings's share price could fall to $13.00 by Dec 11, 2024. The average Hireright Holdings stock price prediction forecasts a potential downside of 8.9% from the current HRT share price of $14.27.

What is HRT's forecast return on equity (ROE) for 2024-2025?

(NYSE: HRT) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.